We’re delighted to present our finalists for the category of “Innovation of the year”:
T-Pro: Real-Time Relief: How T-Pro Copilot is helping the NHS beat burnout and boost efficiency
Overview: T-Pro Copilot is a fully integrated, AI-powered assistant that listens during consultations and creates structured clinical notes in real time. It reduces clinician burden, improves data accuracy, drives safety, and enhances workflow efficiency – empowering NHS trusts to deliver faster, more meaningful, patient-centred care.
What happened? Copilot is designed to ambiently listen to the clinical consultation, capture relevant dialogue, and generate high-quality notes in real time. These notes are fully structured, formatted to fit the clinician’s documentation style, and are easily adapted across clinical specialties. The system allows for voice-enabled editing and approval. The platform is fully compliant with NHS DSP Toolkit requirements, as well as GDPR, HIPAA, ISO 27001, DCB0129 and SOC 2 Type 2 standards. NHS data remains within UK and EU jurisdictions at all times. Copilot integrates deeply with leading NHS EHR systems, offering interoperability that fits seamlessly into everyday practice. Clinicians can generate, review, and approve notes directly within their EHR or via T-Pro’s own interface. Another key strength of Copilot lies in its clinical note outputs. These are not just transcriptions, but intelligent, structured notes coded with AI-suggested terms that support ICD-10, SNOMED-CT, and HL7/FHIR-compliant formatting. The system is also highly flexible and customisable. Feedback from users has been positive. Clinicians report saving 1-2 hours per day by shifting documentation away from post-clinic typing to real-time capture.
Immersive Technology Lab, Lucy Cavendish College, University of Cambridge: Virtual reality public speaking
Overview: Using AI and VR to treat speech anxiety. Multiple world-firsts were achieved to make the platform uniquely effective (significantly reducing anxiety after a single 30-minute session – the associated research paper is in the top 1 percent of research outputs). Launched this year, the platform has already hosted over 100,000 sessions.
What happened? Tailored course material develops core skills and virtual reality training environments accelerate learning and build confidence. Free for all patients globally, the platform has already hosted over 100,000 patient sessions. By developing a method that converts smartphones into VR headsets, we made sure that the platform is accessible to all. The efficacy is increased with Overexposure Therapy (VROT): the ability to repeatedly practice in extreme scenarios such as hyper-distracting stadiums. As revealed in our first clinical trial (now published in Frontiers), when comparing the before and after intervention results, the data revealed a decrease of 45 percentage points in students who describe themselves as anxious public speakers (65 percent vs 20 percent; ?2 (1) = 11.077, p = 0.0008; Cohen’s h = 0.474), an increase of 48 percentage points in students who describe themselves as confident public speakers (31 percent vs 79 percent; ?2 (1) = 12.071, p = 0.0005; Cohen’s h = 0.504), and an increase of 52 percentage points in students who stated that they enjoy public speaking (34 percent vs 86 percent; ?2 (1) = 13.067, p = 0.0003, Cohen’s h = 0.565). In the most recent trial, it was found that a week of self-guided use was beneficial to 100 percent of patients.
Prescribe Digital: AISA®: The silent assistant that clinicians trust
Overview: AISA® listens unobtrusively during consultations to produce accurate, structured clinical notes – reducing admin fatigue, improving accuracy, and freeing clinicians to focus on patients. With Amplify+® integration and QA oversight, AISA® adapts to real NHS workflows – making it an essential companion, not just a tool.
What happened? AISA® combines proprietary UK-tuned language models, medical NLP, and contextual filtering to ensure only relevant clinical content is captured. It requires no wake words or prompts, differentiates clinical from non-clinical speech, structures output into SOAP notes, GP letters and adapted patient communication automatically, and outlines next steps such as referrals, treatment plans or medication entries. It integrates into existing workflows and allows full review before sign-off. AISA® is embedded within the Amplify+® clinical documentation platform, enabling clinicians to move fluidly between ambient capture (AISA®), structured voice dictation, and traditional transcription with human QA. Outputs are inserted directly into EPRs via HL7 or FHIR standards. From NHS pilots and deployments, AISA® has delivered up to five hours/week reclaimed per clinician, a significant reduction in after-hours documentation, higher accuracy and richer clinical content, fewer revisions and rework cycles, and enhanced job satisfaction and wellbeing. AISA® complies with NHS information governance standards, is hosted in UK-based Microsoft Azure, ICO registered, Cyber Essentials Plus and ISO27001 aligned, with end-to-end encryption and a full audit trail for all actions.
Cosdent Company Limited: COSDENT Smile Design: Personalised digital innovation for smile planning
Overview: COSDENT Smile Design bridges technology and empathy. As a behavioural design system, it redefines smile planning into a co-created, emotionally resonant digital journey – closing the gap between clinical recommendations and patient expectations, and restoring confidence, identity, and trust in the dental care experience.
What happened? The Smile Design journey follows a five-stage, human-led framework covering facial mapping and aesthetic data capture with high-res photography, digital X-rays, and smile line assessments; patient selection from the in-house Smile Archetype Library; digital co-design with clinicians and patients; a physical mock-up; and final emotional consent. It addresses key issues in traditional dentistry, including high patient anxiety, low treatment uptake, and fragmented communication between clinicians and patients. Outcomes include a 68 percent treatment conversion rate, and a 95 percent post-treatment satisfaction rate. Clinicians report improved clarity in treatment planning and greater patient engagement. Technologies integrated into the patient journey include a zero-pain cleaning system that uses pressurised air and water to remove stains in 10-15 minutes; digital X-ray systems which reduce radiation exposure by 70 percent and deliver instant results; and advanced laser technology used for gum contouring, pigmentation treatment, and even snoring therapy – delivering precision care with minimal bleeding and faster recovery.
Strolll: Rewriting rehab through augmented reality
Overview: Strolll’s AR platform transforms neurorehabilitation, turning paper exercises into immersive therapy patients want to complete. It closes the rehab gap caused by staffing shortages, boosts adherence, reduces falls, and shortens hospital stays. Backed by NHS trials, global partnerships, and £15m+ in funding, Strolll is changing recovery.
What happened? Strolll is a digital therapeutic platform that delivers gamified augmented reality rehabilitation through lightweight smart glasses. Instead of sporadic appointments or paper handouts, patients can engage in interactive rehab exercises anytime, in the hospital gym, on the ward, or at home after discharge. Picture a patient walking down a virtual forest path overlaid on their hospital corridor, stepping over virtual logs to practise their gait, or reaching out to catch virtual objects to improve their balance. All the while, the AR system is delivering proven therapy exercises in the form of a game, one that’s fun, safe, and designed by clinicians and patients. A single therapist can supervise multiple patients or let the software guide patients through exercises outside of 1:1 sessions. In fact, clinical trials published in 2024 demonstrated that using Strolll, clinicians were able to deliver up to seven times more treatment sessions with significantly less staff time required. The same trials showed a 104 percent adherence rate, meaning patients often exceeded their prescribed therapy dose. Patients gain more hours of therapy per day, which leads to faster improvements in mobility and function. Rehabilitation can continue at home seamlessly, reducing readmission risk.
TherapyFast: Innovating mental health with on-demand AI therapy
Overview: TherapyFast tackles the global mental health crisis by eliminating barriers to therapy. The AI-powered app delivers instant, accessible support anytime, reducing waiting lists and stigma. By blending clinical expertise with technology, we’ve reached thousands, empowering users and stakeholders with scalable, effective solutions.
What happened? TherapyFast is an AI-powered therapy app trained on thousands of hours of clinically validated therapy literature. There are no waiting lists. Users can engage in therapy the moment they need it, from anywhere in the world. Advanced AI avatars simulate genuine human interactions, and the solution integrates best practices from CBT, solution-focused therapy, and more, constantly reviewed by licensed psychologists. The platform supports multiple languages and cultural backgrounds. Our AI models, built on leading-edge large language models and trained on proprietary datasets, are uniquely fine-tuned for therapeutic conversations. We layered custom safety protocols, escalation paths, and privacy features on top of the core engine, ensuring the system could detect crisis situations and provide urgent resources or connect to human help as required. TherapyFast’s essential feature are free to ensure cost would never be a barrier. Since its launch, TherapyFast has reached over 15,000 users. In user surveys, 83 percent reported improved wellbeing within one month. Importantly, over half of users had never previously sought any form of therapy – showing TherapyFast is breaking down traditional barriers.
Pulsetto: Pulsetto-FIT
Overview: Pulsetto, a non-invasive vagus nerve stimulation, helps people reduce stress, sleep better, and boost mental well-being. Now with an improved fit and optimised stimulation, Pulsetto-FIT makes every session even more effective.
What happened? Pulsetto-FIT combines hands-free design and is the only device providing bilateral VNS on the neck – delivering effective and comprehensive results. Pulsetto directly targets the vagus nerve at the neck for maximum impact on sleep, stress, pain, gut health, and overall well-being. Its customisable programmes and intuitive interface let users tailor their experience. In a four week clinical study involving 40 participants, Pulsetto was used twice daily following a standardised stimulation protocol (8 minutes per session, using the ANXIETY program, at least level 5 intensity, applied once in the morning and once before sleep). Validated clinical questionnaires showed significant improvements: stress symptoms (PHQ-9) decreased by 56 percent, anxiety (GAD-7) by 45 percent, and sleep disturbances (PSQI) by 41 percent. In a six week migraine study with 20 participants, daily bilateral stimulation (40 min/day) led to a 40 percent reduction in migraine frequency, 42 percent pain reduction, and a 14 percent improvement in mood.
splose: Transforming Allied Health practice management with seamless AI integration
Overview: splose is an AI-powered practice management platform designed for allied health with 17,000+ users across the globe. It automates clinical and administrative workflows, like documentation, transcription, scheduling, and invoicing, saving hours per week.
What happened? The splose platform brings together all the tools a practice needs in one place. AI-assisted note writing, real-time voice-to-text transcription, auto-generated reports and letters, smart scheduling, batch invoicing, and built-in compliance templates. splose AI is embedded across all core workflows, from drafting progress notes and assessments to summarising speech and generating outcome-based reports, reducing the burden of cognitive switching and enabling faster clinical decision-making. If a practitioner finishes a session, they can record a short voice memo and receive a fully structured, editable note or report summary that aligns with their preferred clinical framework. If they’re unsure how to phrase something for an audit, splose AI can help refine language using real-world, discipline-specific terminology. The Calendar AI feature intelligently manages clinical schedules by analysing practitioner availability, appointment types, and client preferences, then offering smart suggestions to optimise daily bookings. Feedback from clinicians has been that their days feel smoother, with admin teams saying they’ve cut back on back-and-forth with clients, and operations managers reporting higher booking efficiencies.
Oxford Health NHS Foundation Trust: Enhancing Mental Health Act consent to treatment (T2/T3) prescribing with digitisation and decision support in ePMA
Overview: This project created legally compliant digital templates within Better Meds ePMA, enabling full digitisation/management of T2 forms, while allowing T3 forms to be transcribed accurately. It ensures staff have immediate access and can monitor compliance, while clinicians retain flexibility, supported by prompts for Section 62.
What happened? Through collaborative work between the ePMA supplier (Better), the digital medicines team, and the MHA office for Oxford Health Foundation Trust, the project developed T2/T3 functionality that meets all the legal and clinical criteria. During the development of the digital solution, inpatient wards continued to use the paper forms and established processes to manage patient medications, ensuring patient safety remained a priority throughout the transition. The approach taken for this pilot and all subsequent rollouts was to transcribe existing T2/T3 onto ePMA with any subsequent T2s being created directly within ePMA and T3 transcribed by a ward doctor upon receipt of the original from the CQC Second Opinion Doctor (via the MHA office). Initial results from the pilot ward showed significant improvement in all measured areas, including availability of T2/T3 forms on the ward and in our EPS system. There was also significantly improved compliance relating to prescribing within the outlined care plan on the T2/T3 or the availability of a Section 62 where required. Section 62 forms are due for release in the next BetterMeds version update.
Maidstone and Tunbridge Wells NHS Trust: Automated vital signs integration at Maidstone and Tunbridge Wells NHS Trust
Overview: The Trust implemented a fully automated process for capturing and recording vital signs. Through a collaboration between the device provider (Welch Allyn), the EPR vendor, and the Trust’s internal teams, vital signs are transmitted directly from the Welch Allyn devices, through the Trust Integration Engine, into the EPR in real-time.
What happened? The solution includes seamless device-to-EPR integration, real-time data availability on patient flowsheets and ward tracking boards, and retention of manual workflows as a fall-back for resilience during downtime. The rollout followed a carefully phased approach featuring co-development with frontline clinical staff, pilot implementation on a single ward, iterative feedback loops, and collaboration across multiple departments. Since implementation, the Trust has seen substantial improvements, with time-in-motion studies showing a three-minute time saving per observation, equating to approximately 30 minutes saved per observation round on a typical ward. Observations now appear in the EPR within one minute, down from an average of 45 minutes. Earlier identification of deteriorating patients enables faster escalation and improved clinical outcomes, whilst reduced paperwork and transcription allows staff to focus on direct patient care. Availability of structured, real-time data supports capacity planning and patient flow management, and the solution supports national NEWS2 standards and enhances clinical information governance. The model is now being shared with neighbouring Trusts as a regional exemplar of best practice.
Symphysis Medical: releaze
Overview: releaze is a novel drainage catheter system that will be significantly more effective and a more patient-friendly device for managing fluid in the chest in terminal cancers in the home setting compared to current drainage devices. Patients drain themselves without the need for a nurse/carer due to the novel one-handed drainage step.
What happened? A patented subcutaneous ‘anchor’ component allows the drainage tube to be secured via just one incision as opposed to two with standard catheter devices. A reusable drainage hub incorporates sensor-based technology and electronics to revolutionise the drainage process. Our innovative hub features an autostop function and maintains a consistent low-level negative pressure throughout the drainage procedure. A companion remote monitoring system for releaze, integrating both a patient app and a clinician dashboard, is designed to empower patients in managing their drainage schedules effectively while facilitating communication with their clinical team. With releaze, 90 percent or more of home-based patients are predicted to be able to drain independently. The ease of placement, securement of the port in skin, and the performance of the capsule have been tested via bench testing, cadaveric testing and in 10 preclinical studies. A patient study was completed with a top cancer centre in the US, MD Anderson, and the University of Galway to conduct testing on the Patient Companion App prototype, and 90 percent of users found it to be user-friendly. In the University of Galway some routine face to face visits were replaced by monitoring of patients’ progress via the app data.
